Who Generates More Revenue? Vertex Pharmaceuticals Incorporated or Bausch Health Companies Inc.

Vertex Overtakes Bausch in Revenue by 2023

__timestampBausch Health Companies Inc.Vertex Pharmaceuticals Incorporated
Wednesday, January 1, 20148263500000580415000
Thursday, January 1, 2015104988000001032336000
Friday, January 1, 201696740000001702177000
Sunday, January 1, 201787240000002488652000
Monday, January 1, 201883800000003047597000
Tuesday, January 1, 201986010000004162821000
Wednesday, January 1, 202080270000006205683000
Friday, January 1, 202184340000007574400000
Saturday, January 1, 202281240000008930700000
Sunday, January 1, 202387570000009869200000
Monday, January 1, 202411020100000
Loading chart...

Cracking the code

Revenue Race: Vertex vs. Bausch Health

In the competitive landscape of pharmaceuticals, revenue generation is a key indicator of success. Over the past decade, Vertex Pharmaceuticals Incorporated and Bausch Health Companies Inc. have been vying for dominance. From 2014 to 2023, Bausch Health consistently led the revenue race until 2022, when Vertex Pharmaceuticals surged ahead.

In 2014, Bausch Health's revenue was nearly 14 times that of Vertex. However, Vertex's strategic innovations and market expansions led to a remarkable growth trajectory, culminating in a 70% increase in revenue from 2020 to 2023. By 2023, Vertex outpaced Bausch Health, generating approximately 13% more revenue.

This shift highlights Vertex's dynamic growth strategy and Bausch Health's steady, albeit slower, revenue stream. As the pharmaceutical industry evolves, these companies exemplify the diverse paths to financial success.

Published by
U.S. Securities and Exchange Commission

Source link
sec.gov

Date published
17 Jan 2025